Russian MPs warn of security threats in Europe due to undermining dialogue with Russia
Amsterdam court receives Ukraine’s statement on Scythian gold
Russian Defence Ministry not to cut back on State Program of Armaments until 2020
DPR head: statements of Poroshenko, Biden about local election in Donbas are 'inadequate'
Serbia has taken no decision on participation in Turkish Stream project
Russia’s parliament gives citizens 'right to be forgotten in Internet'Russia July 03, 14:58
Ukraine draft constitution fails to fulfil requirements of Minsk deal — LavrovRussia July 03, 14:44
Finland sets dangerous precedent denying entry to Russian delegation — Russia’s OSCE envoyRussia July 03, 14:30
Foreign financing of Russian NGOs surge in 2014-2015 — financial monitoring authoritiesEconomy July 03, 14:16
Russian MP calls BRICS one of factors deterring dictatorial ambitions in modern worldRussia July 03, 13:51
DPR head: statements of Poroshenko, Biden about local election in Donbas are 'inadequate'World July 03, 13:43
EU can play more active role in Ukrainian crisis settlement — LavrovRussia July 03, 13:29
Restoration of US-Cuba ties act of historical justice — Russian Foreign MinistryRussia July 03, 12:58
Russian Defence Ministry not to cut back on State Program of Armaments until 2020Russia July 03, 12:55
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.